GU Cancers 2022 | Unanswered questions in the management of clear cell RCC

Mehmet Bilen, MD, Emory Winship Cancer Institute, Atlanta, GA, discusses the key unanswered questions in the management of clear cell renal cell carcinoma (ccRCC), including the need for improvements in biomarkers and sequencing in order to provide personalised treatments for patients. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.